SCHEMBL18178258

SCHEMBL18178258

COC(=O)Oc1cccc(C)c1COc1cc(Cl)c(C)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 1/20 0.41
LMNA P02545 4/20 0.40
RAB9A P51151 4/20 0.40
NPC1 O15118 3/20 0.40
KDM4E B2RXH2 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SGMS2 Q8NHU3 1/20 0.39
THRB P10828 1/20 0.39
MAPT P10636 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MRGPRX4 Q96LA9 5/20 0.38
AKR1C3 P42330 2/20 0.38
PTPN1 P18031 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178356 0.94 SLC22A12 (0.41) SLC22A12LMNARAB9AKDM4ESMN1; SMN2
SCHEMBL18178278 0.93 SLC22A12 (0.43) SLC22A12LMNARAB9ANPC1KDM4E
SCHEMBL18178261 0.93 NPC1 (0.40) LMNARAB9ANPC1KDM4ESMN1; SMN2
SCHEMBL18182008 0.90 MRGPRX4 (0.39) SLC22A12LMNARAB9ANPC1KDM4E
SCHEMBL18178253 0.90 KDM4E (0.41) LMNARAB9ANPC1KDM4ESMN1; SMN2
SCHEMBL18178286 0.90 SLC22A12 (0.39) SLC22A12LMNARAB9ANPC1KDM4E
SCHEMBL18178260 0.90 MRGPRX4 (0.41) LMNARAB9ANPC1KDM4ESMN1; SMN2
SCHEMBL18178256 0.90 LMNA (0.39) LMNARAB9ANPC1KDM4ESMN1; SMN2
SCHEMBL18178249 0.90 LMNA (0.39) SLC22A12LMNARAB9ANPC1KDM4E
SCHEMBL18178257 0.90 LMNA (0.41) LMNARAB9ANPC1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 SLC22A12 4500/4885LMNA 4171/4885RAB9A 1136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.